Clinical Trial Update: Safety of RIV4 Versus IIV4 in Pregnant Women [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety of RIV4 compared with IIV4 in pregnant women; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adverse Birth Outcomes
• Pregnancy Complications

Drugs mentioned

• IIV4 (inactivated influenza vaccine for quadrivalent formulation)
• RIV4

Snippet

Sponsor: Duke University | Conditions: Safety, Adverse Event Following Immunisation | Phase 4 | Status: COMPLETED | Results posted: 2022-12-27